Weight-loss medications surged in popularity this year. A survey from Kaiser Family Foundation found one in eight adults have ...

Nearly 75% of Americans are classified as overweight or obese. Addressing our nation's health crisis requires much more than ...

Elon Musk has revealed he has upgraded from Ozempic to Mounjaro, nicknamed the “King Kong” of weight-loss drugs, in a photo ...

Health secretary Wes Streeting has backed the prescribing of the drugs to obese patients in the hope it can tackle the nation ...

Groundbreaking weight-loss drugs like Ozempic and Wegovy have understandably generated a lot of excitement, bringing hope to the hundreds of millions of people grappling with obesity. When combined ...

The scathing post also included a photo of herself “pretending to eat a chocolate” at the “height” of her “anorexia” battle ...

Mounjaro, which has been dubbed the "King Kong" of weight-loss drugs, is considered more effective than its competitors with ...

Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.

A study suggests that GLP-1 agonist drugs, like Ozempic, may reduce overdose risks and aid in addiction treatment. Further ...

This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...

The poll comes as U.S. obesity rates continue to pose a major health problem, leading to high rates of heart disease and diabetes.

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...